$VSXY

Wells Fargo Sees ‘Significant’ 2028 EPS Potential For Victoria’s Secret, Raises Target To $120

Wells Fargo raised its price target for Victoria's Secret (VSKY) to $120, citing strong sales and earnings growth potential. The company is expected to report Q3 2026 EPS of $1.45 and revenue of $1.97B. Analysts are mixed, with 7 of 13 rating it 'Buy' or 'Strong Buy'. Shares have gained over 9% in the past month.

Original reporting
Published Nov 3, 2026, 4:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wells Fargo Sees ‘Significant’ 2028 EPS Potential For Victoria’s Secret, Raises Target To $120 — source image
Decision brief

The 30-second read

$VSXYBullishMed
01

Why it matters

The immediate tradable input is the raised $120 target and the stated thesis (durable comps momentum, higher margin targets, significant 2028 EPS power), which can influence positioning ahead of the Dec 2 earnings date.

02

Market read

A broker PT increase with a clear operating thesis can move expectations into the next earnings catalyst, even without new company guidance.

03

What to watch

Key risk is whether margin targets are achievable without promotional intensity or cost headwinds; the piece also relies on third-party data (Koyfin/Fiscal.AI) rather than new filings.

Relevance 6/10Novelty 5/10Timing: ahead of the Dec 2 fiscal Q3 2026 earnings report

Background

The article frames Victoria's Secret’s turnaround narrative, highlighting Wells Fargo’s view that results under CEO Hillary Super are the best in a decade.

Company-level read

Ticker impact

$VSXYBullishMedium confidence
Context

Wells Fargo raised its Victoria's Secret price target to $120 from $100, citing durable comparable-sales momentum and higher margin targets.

Expected impact

Likely near-term support as traders price in continued margin expansion and sustained comparable-sales momentum.

Evidence & confidence

The article is specifically about a fresh Wells Fargo target increase tied to concrete operating drivers (comps momentum, margin targets) and notes the stock is up modestly at the time of writing.

Market effects

Adds incremental bullish sentiment to apparel retail turnarounds, potentially supporting sentiment toward other specialty retailers with improving traffic and transactions.

Primarily US retail sentiment; limited direct regional spillover implied.

Low global relevance, as the catalyst is company-specific analyst commentary ahead of US earnings.

Counterpoint

PT hikes can lag reality if comparable-sales momentum fades; the article does not provide new company guidance, only the analyst’s view.

Key entities

  • Victoria's Secret

    Retailer whose turnaround and earnings power are discussed, with a Wells Fargo price-target increase.

  • Wells Fargo

    Brokerage raising the price target and citing operating momentum and margin outlook.

  • Hillary Super

    CEO referenced as driving improved performance.

Related articles

$VSXYMed

Victoria's Secret (VSXY) stock trades up, here is why

Victoria's Secret (VSXY) stock rose 5.1% after analysts raised price targets and issued positive ratings. Barclays, Morgan Stanley, and Needham analysts cited strong demand, momentum, and a multi-year turnaround. The company's shares have been volatile, with a 79.3% gain YTD. Q3 results beat estimates, with revenue of $1.47B and same-store sales up 8%.

$AZNHigh

Why AZN, VSXY, EYPT Stocks Are Moving Premarket Today

AstraZeneca (AZN) shares rose 1.8% premarket after Oracle (ORCL) announced a non-binding AI collaboration. Victoria’s Secret (VSXY) gained 1% following a Barclays price target increase to $112. EyePoint Pharmaceuticals (EYPT) fell 4.4% after JPMorgan downgraded it to 'Underweight' due to a clinical trial setback.

$VSXYHigh

Victoria’s Secret Is Bringing Sexy Back

Victoria’s Secret revived its iconic Angels, Fantasy Bra, and glamorous imagery at its 2026 fashion show, marking a shift from its 2021 rebranding. The company reported $1.611B in Q2 net sales, up 10% YoY, and raised its full-year sales forecast. Analyst Simeon Siegel notes the brand's challenge is restoring cultural relevance, which could support pricing power and business health.

$VSXYMed

How Investors May Respond To Victoria's Secret Stock After Raised Guidance

Victoria's Secret & Co. reported Q2 2026 net sales up 10% and adjusted EPS nearly tripled, raising full-year guidance for sales, operating income, and EPS. The company's Path to Potential plan showed five quarters of positive comparable sales, driven by international demand and new customer acquisition. Analysts debate the sustainability of this momentum and the impact of store exposure, tariffs, and debt. The stock's valuation and future earnings growth are key focus areas.

$VSXYMedAI 8/10

VS&Co (VSXY): Wall Street Debates Whether the Turnaround Is Already Priced In

Victorias Secret & Co. (VSXY) reported Q2 2026 net sales up 10% to $1.611B, adjusted EPS nearly tripled to $0.95, and raised full-year guidance. Analysts are divided: Morgan Stanley, Barclays, and JPMorgan see the turnaround continuing, while BMO and UBS believe the stock already reflects recovery. Hedge funds adjusted stakes, with Arrowstreet Capital increasing its position by 47%.